• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Post-sequelae symptoms and comorbidities after COVID-19

tetano

Editor, Senior Moderator
J Med Virol


. 2022 Jan 14.
doi: 10.1002/jmv.27586. Online ahead of print.
Post-sequelae symptoms and comorbidities after COVID-19


Priya Duggal[SUP] 1 2 [/SUP], Tristan Penson[SUP] 2 [/SUP], Hannah N Manley[SUP] 1 [/SUP], Candelaria Vergara[SUP] 1 [/SUP], Rebecca M Munday[SUP] 3 [/SUP], Dylan Duchen[SUP] 1 [/SUP], Elizabeth A Linton[SUP] 1 [/SUP], Amber Zurn[SUP] 1 [/SUP], Jeanne C Keruly[SUP] 2 [/SUP], Shruti H Mehta[SUP] 1 2 [/SUP], David L Thomas[SUP] 1 2 [/SUP]



Affiliations

Abstract

Background: The frequency, severity, and forms of symptoms months after coronavirus 2019 (COVID-19) are poorly understood, especially in community settings.
Objective: To characterize symptoms months after community-based COVID-19.
Design: Retrospective cohort analysis.
Setting: Persons testing positive for SARS-CoV-2 RNA in the Johns Hopkins Health System, Maryland.
Patients: 328 consecutive persons with a positive test for SARS-CoV-2 March-May 2020.
Measurements: symptom occurrence and severity by administered questionnaire.
Results: Of 328 persons evaluated a median of 242 days (109 to 478 days) from initial positive SARS-CoV-2 test, 33.2% reported not being fully recovered and 4.9% reported symptoms that constrained daily activities. Compared to those who reported being fully recovered, those with post-acute sequelae were more likely to report a prior history of heart attack (p<0.01. Among those reporting long-term symptoms, men and women were equally represented (men= 34.8%, women= 34.6%), but only women reported symptoms that constrained daily activities, and 56% of them were caregivers. The types of new or persistent symptoms varied, and for many, included a deviation from prior COVID-19 health, such as being less able to exercise, walk, concentrate, or breathe.
Limitation: Self-report of symptoms might be biased and/or caused by factors other than COVID-19.
Conclusion: Even in a community setting, symptoms may persist months after COVID-19 reducing daily activities including caring for dependents. This article is protected by copyright. All rights reserved.

Keywords: Post-COVID-19; SARS-CoV-2; long-haul; sequela.
 
Back
Top Bottom